On 2024-05-13, Leap Therapeutics, Inc. (LPTX) announced earnings per share of $-0.51 for the fiscal quarter ending 2024-03-31, beating the average analyst estimate of $-0.57.
The next expected annoucement date for quarterly earnings is 2024-08-12, with an average estimated earnings per share of $-0.42 for the fiscal quarter ending 2024-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-05-13 | 2024-03-31 | $-0.57 | $-0.51 |
| 2024-03-18 | 2023-12-31 | $-0.56 | $-0.46 |
| 2023-11-13 | 2023-09-30 | $-0.48 | $-0.51 |
| 2023-08-14 | 2023-06-30 | $-0.98 | $-0.91 |
| 2023-05-15 | 2023-03-31 | $-0.90 | $-3.20 |
| 2023-03-24 | 2022-12-31 | $-0.90 | $-1.10 |
| 2022-11-14 | 2022-09-30 | $-1.10 | $-1.30 |
| 2022-08-12 | 2022-06-30 | $-1.00 | $-1.50 |
| 2022-05-13 | 2022-03-31 | $-1.10 | $-0.90 |
| 2022-03-11 | 2021-12-31 | $-1.10 | $-1.00 |
| 2021-11-12 | 2021-09-30 | $-1.10 | $-1.40 |
| 2021-08-13 | 2021-06-30 | $-1.30 | $-1.20 |
| 2021-05-14 | 2021-03-31 | $-1.10 | $-1.20 |
| 2021-03-12 | 2020-12-31 | $-0.80 | $-0.90 |
| 2020-11-12 | 2020-09-30 | $-1.20 | $-0.90 |
| 2020-08-13 | 2020-06-30 | $-1.70 | $-1.20 |
| 2020-05-14 | 2020-03-31 | $-2.60 | $-5.50 |
| 2020-03-16 | 2019-12-31 | $-3.20 | $-3.30 |
| 2019-11-14 | 2019-09-30 | $-3.30 | $-3.30 |
| 2019-08-09 | 2019-06-30 | $-4.00 | $-3.70 |
| 2019-05-15 | 2019-03-31 | $-4.20 | $-4.70 |
| 2019-04-01 | 2018-12-31 | $-6.30 | $-5.00 |
| 2018-11-09 | 2018-09-30 | $-4.20 | $-6.70 |
| 2018-08-08 | 2018-06-30 | $-4.80 | $-4.50 |
| 2018-05-11 | 2018-03-31 | $-4.90 | $-4.60 |
| 2018-02-23 | 2017-12-31 | $-7.70 | $-6.50 |
| 2017-11-13 | 2017-09-30 | $-4.30 | $-7.30 |
| 2017-08-11 | 2017-06-30 | $-5.00 | $-7.40 |
| 2017-05-12 | 2017-03-31 | $-8.50 | $-13.90 |